Nymox Pharmaceutical Corp (NYMX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nymox Pharmaceutical Corp (NYMX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011102
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:バハマ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the diagnosis of Alzheimer’s disease. Its diagnostic product portfolio includes NicAlert test to determine smoking status; and TobacAlert home test to determine person’s level of exposure to tobacco products, including second hand smoke. Nymox’s lead drug candidate, NX-1207 is being developed for the treatment of BPH (benign prostatic hyperplasia) and certain types of cancer. It operates has subsidiaries in New Jersey, the US. Nymox is headquartered in Nassau, the Bahamas.

Nymox Pharmaceutical Corp (NYMX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nymox Pharmaceutical Corp, Medical Equipment, Deal Details 10
Equity Offering 10
Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 10
Nymox Pharmaceutical to Raise USD12 Million in Private Placement 11
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 12
Nymox Pharmaceutical Corp – Key Competitors 13
Nymox Pharmaceutical Corp – Key Employees 14
Nymox Pharmaceutical Corp – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Nymox Pharmaceutical Corp, Medical Equipment, Key Facts, 2016 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nymox Pharmaceutical Corp, Deals By Market, 2011 to YTD 2017 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 10
Nymox Pharmaceutical to Raise USD12 Million in Private Placement 11
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 12
Nymox Pharmaceutical Corp, Key Competitors 13
Nymox Pharmaceutical Corp, Key Employees 14
Nymox Pharmaceutical Corp, Other Locations 15
Nymox Pharmaceutical Corp, Subsidiaries 15

★海外企業調査レポート[Nymox Pharmaceutical Corp (NYMX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abu Dhabi National Energy Co (TAQA):電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi National Energy Company (TAQA), a subsidiary of government-owned Abu Dhabi Water and Electricity Authority, is an energy and water company. It undertakes power generation; exploration, development, production and storage of oil and gas; pipelines and gas storage; and water desalina …
  • Karolinska Development AB (KDEV):企業の財務・戦略的SWOT分析
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company that strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase 1 …
  • Zagro Asia Ltd:企業の戦略的SWOT分析
    Zagro Asia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • German Cancer Research Center-医療機器分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • Alcon Inc (ALC):企業の財務・戦略的SWOT分析
    Alcon Inc (ALC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Air Liquide SA:企業の戦略・SWOT・財務情報
    Air Liquide SA - Strategy, SWOT and Corporate Finance Report Summary Air Liquide SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • Prodware SA:企業の戦略・SWOT・財務情報
    Prodware SA - Strategy, SWOT and Corporate Finance Report Summary Prodware SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Capstone Therapeutics Corp (CAPS)-製薬・医療分野:企業M&A・提携分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops novel peptides and other molecules. The company develops novel peptides to support patients with under-served medical conditions. It develops AZX100 and Chrysalin drug platforms. Capstone …
  • Service Corporation International (SCI):企業の財務・戦略的SWOT分析
    Service Corporation International (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Shimadzu Corp (7701)
    Shimadzu Corp (7701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Activision Blizzard, Inc.:企業の戦略・SWOT・財務情報
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • J&P – Avax Sa
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • EDF Luminus SA:発電所・企業SWOT分析
    EDF Luminus SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Mitsubishi Heavy Industries Ltd (7011)-エネルギー分野:企業M&A・提携分析
    Summary Mitsubishi Heavy Industries Ltd (MHI) is a manufacturer of heavy machinery. It offers a diverse range of products and services for power plants, chemical plants, environmental equipment, steel structures, industrial and general machinery, shipbuilding, aircraft, space systems and air-conditi …
  • Bank of Singapore Ltd.:企業の戦略・SWOT・財務情報
    Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Gunma Bank Ltd
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆